These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 21091117)
1. Immunotherapy of systemic sclerosis. Manno R; Boin F Immunotherapy; 2010 Nov; 2(6):863-78. PubMed ID: 21091117 [TBL] [Abstract][Full Text] [Related]
2. Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials. Au K; Khanna D; Clements PJ; Furst DE; Tashkin DP Curr Rheumatol Rep; 2009 Apr; 11(2):111-9. PubMed ID: 19296883 [TBL] [Abstract][Full Text] [Related]
3. A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide. Sabnani I; Zucker MJ; Rosenstein ED; Baran DA; Arroyo LH; Tsang P; Zubair M; Rivera V Rheumatology (Oxford); 2009 Jan; 48(1):49-52. PubMed ID: 18815156 [TBL] [Abstract][Full Text] [Related]
4. Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Fraticelli P; Gabrielli B; Pomponio G; Valentini G; Bosello S; Riboldi P; Gerosa M; Faggioli P; Giacomelli R; Del Papa N; Gerli R; Lunardi C; Bombardieri S; Malorni W; Corvetta A; Moroncini G; Gabrielli A; Arthritis Res Ther; 2014 Jul; 16(4):R144. PubMed ID: 25007944 [TBL] [Abstract][Full Text] [Related]
5. Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases? Beyer C; Distler JH; Distler O Swiss Med Wkly; 2010; 140():w13050. PubMed ID: 20419513 [TBL] [Abstract][Full Text] [Related]
14. Future treatments in systemic sclerosis. Asano Y J Dermatol; 2010 Jan; 37(1):54-70. PubMed ID: 20175840 [TBL] [Abstract][Full Text] [Related]
15. A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease. Khanna D; Saggar R; Mayes MD; Abtin F; Clements PJ; Maranian P; Assassi S; Saggar R; Singh RR; Furst DE Arthritis Rheum; 2011 Nov; 63(11):3540-6. PubMed ID: 21769849 [TBL] [Abstract][Full Text] [Related]
16. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. van Laar JM; Farge D; Tyndall A Ann Rheum Dis; 2005 Oct; 64(10):1515. PubMed ID: 16162905 [No Abstract] [Full Text] [Related]
17. Recent advances in the treatment of systemic sclerosis. Bournia VK; Vlachoyiannopoulos PG; Selmi C; Moutsopoulos HM; Gershwin ME Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):176-200. PubMed ID: 19132559 [TBL] [Abstract][Full Text] [Related]
18. Stem cells: HSCT for systemic sclerosis--swallows and summers. Tyndall A Nat Rev Rheumatol; 2011 Sep; 7(11):624-6. PubMed ID: 21912430 [No Abstract] [Full Text] [Related]